Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Gynecologic × 30 days × Clear all

Phase

Status

Recruiting 189 Active not recruiting 88 Completed 38 Not yet recruiting 31 Terminated 11 Enrolling by invitation 4 Suspended 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Thoracic 4 Lymphoid 4 Breast 4 Genitourinary 3 Tumor-Agnostic 2 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Ovarian Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07060365 2026-04-03

A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer

AstraZeneca

Phase 1/2 Withdrawn

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡